English
Home > Products > CAS:58-22-0

China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • Methylprednisolone Hemisuccinate

    Methylprednisolone Hemisuccinate

    For Methylprednisolone Hemisuccinate, we have EP, USP and CP specification. DMF and WC available.

    CAS:2921-57-5

  • Testosterone Undecanoate

    Testosterone Undecanoate

    Testosterone undecanoate has CP specification. TP available and DMF under filing.

    CAS:5949-44-0

  • Oseltamivir Phosphate

    Oseltamivir Phosphate

    Oseltamivir Phosphate has CP ,EP and USP specifications. DMF available.

    CAS:204255-11-8

  • Lasmiditan Succinate

    Lasmiditan Succinate

    Lasmiditan Succinate has In-house specification. DMF approved.

    CAS:439239-92-6

  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • Epiandrosterone

    Epiandrosterone

    Epiandrosterone is a steroid hormone with weak androgenic activity. It is a metabolite of testosterone and dihydrotestosterone (DHT).

    CAS:481-29-8

  • Related Blog
  • Reviews

  • 2019 CPhI China Exhibition Shanghai

    June 2019
    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2024 Exhibition Calendar: Connect with Us and Explore New Possibilities!

    Our 2024 Exhibition Calendar has been announced! Come meet our team and explore new business opportunities.We look forward to seeing you there!

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

  • Join Us at Booth N25 for CPHI Korea 2025 in Seoul

  • Visit us at CPHI Frankfurt - Booth 12.1C3!

    CPHI Frankfurt 2025 will be held at Messe Frankfurt from October 28 to 30, our booth number is 12.1C3.

  • What Are The Best Practices For Creating Intermediates Category Content

    For two decades at Google, my daily focus was unraveling how users search and what content truly satisfies their intent. One of the most persistent challenges I’ve seen businesses face is effectively presenting their specialized products, especially in technical niches. This is particularly true when crafting content for an Intermediates Category.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept